2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 61.781 | 151.493 | 263.114 | 355.110 | 346.930 | 497.585 | 952.874 | 859.267 | 1.206.322 | 1.496.081 |
Total Income - EUR | 64.468 | 153.048 | 263.319 | 355.110 | 347.555 | 499.912 | 956.732 | 859.812 | 1.206.337 | 1.519.007 |
Total Expenses - EUR | 27.349 | 77.148 | 110.028 | 127.918 | 164.592 | 327.153 | 632.970 | 706.524 | 890.792 | 1.073.127 |
Gross Profit/Loss - EUR | 37.119 | 75.900 | 153.290 | 227.192 | 182.963 | 172.759 | 323.763 | 153.289 | 315.545 | 445.879 |
Net Profit/Loss - EUR | 35.271 | 63.750 | 128.744 | 220.850 | 179.487 | 167.769 | 315.122 | 144.688 | 289.979 | 382.745 |
Employees | 4 | 0 | 2 | 0 | 2 | 6 | 13 | 19 | 16 | 18 |
Check the financial reports for the company - Gyn - Med S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 93.425 | 79.428 | 166.530 | 278.135 | 596.660 | 572.377 | 542.875 | 482.156 | 532.179 | 649.666 |
Current Assets | 71.401 | 158.068 | 199.860 | 297.049 | 159.717 | 341.102 | 692.101 | 456.387 | 728.710 | 695.714 |
Inventories | 0 | 0 | 802 | 0 | 0 | 2.408 | 0 | 0 | 157 | 4.917 |
Receivables | 933 | 341 | 332 | 0 | 27.501 | 4.674 | 5.466 | 16.612 | 18.679 | 25.770 |
Cash | 25.826 | 0 | 198.726 | 297.049 | 132.215 | 123.290 | 376.532 | 439.775 | 709.874 | 665.026 |
Shareholders Funds | 131.074 | 195.918 | 322.664 | 538.051 | 707.664 | 861.871 | 1.160.655 | 875.302 | 1.167.996 | 1.258.100 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 33.752 | 41.578 | 43.727 | 37.132 | 48.712 | 51.607 | 74.321 | 63.241 | 92.892 | 87.279 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year |
8622
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Gyn - Med S.r.l.